{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:51:53Z","timestamp":1792601513158,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.micpath.2025.107409","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T11:57:32Z","timestamp":1740398252000},"page":"107409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Protective effect of ginsenoside CK against MPTP-induced Parkinson\u2019 s disease mouse model by suppressing oxidative stress and inflammation, and modulating the gut microbiota"],"prefix":"10.1016","volume":"202","author":[{"given":"Xu","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinnan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.micpath.2025.107409_bib1","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1111\/ene.14851","article-title":"Emerging concepts on bradykinesia in non-parkinsonian conditions","volume":"28","author":"Paparella","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"9","key":"10.1016\/j.micpath.2025.107409_bib2","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.3390\/ijms23094508","article-title":"Pathophysiological features of nigral dopaminergic neurons in animal models of Parkinson's disease","volume":"23","author":"Guatteo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2025.107409_bib3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/7854_2014_317","article-title":"Clinical and pathological features of Parkinson's disease","volume":"22","author":"Schneider","year":"2015","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.micpath.2025.107409_bib4","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.parkreldis.2004.10.012","article-title":"Pathogenesis of nigral cell death in Parkinson's disease","volume":"11","author":"Przedborski","year":"2005","journal-title":"Park. Relat. Disord."},{"issue":"2","key":"10.1016\/j.micpath.2025.107409_bib5","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/mds.29269","article-title":"Morpho-functional changes of nigral dopamine neurons in an \u03b1-synuclein model of Parkinson's disease","volume":"38","author":"Ledonne","year":"2023","journal-title":"Mov. Disord. : Off. J. Move. Disorder Soc."},{"key":"10.1016\/j.micpath.2025.107409_bib6","article-title":"Parkinson's disease: can targeting inflammation Be an effective neuroprotective strategy?","volume":"14","author":"Gundersen","year":"2021","journal-title":"Front. Neurosci-Switz."},{"issue":"2","key":"10.1016\/j.micpath.2025.107409_bib7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3390\/biomedicines10020371","article-title":"Emerging therapeutic strategies for Parkinson's disease and future prospects: a 2021 update","volume":"10","author":"Gouda","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.micpath.2025.107409_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5582\/ddt.2015.01004","article-title":"Chemical constituents and bioactivities of Panax ginseng (C. A. Mey.)","volume":"9","author":"Ru","year":"2015","journal-title":"Drug. Discov. Ther."},{"issue":"7","key":"10.1016\/j.micpath.2025.107409_bib9","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1089\/acm.2017.0361","article-title":"Ginseng as a treatment for fatigue: a systematic review","volume":"24","author":"Arring","year":"2018","journal-title":"J. Alternative Compl. Med."},{"issue":"4","key":"10.1016\/j.micpath.2025.107409_bib10","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/ptr.7395","article-title":"Ginsenosides in central nervous system diseases: pharmacological actions, mechanisms, and therapeutics","volume":"36","author":"Lu","year":"2022","journal-title":"Phytother Res."},{"issue":"9","key":"10.1016\/j.micpath.2025.107409_bib11","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3390\/biom12091310","article-title":"Ginsenoside and its therapeutic potential for cognitive impairment","volume":"12","author":"Feng","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.micpath.2025.107409_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.116938","article-title":"Synergistic anticancer effects of ginsenoside CK and gefitinib against gefitinib-resistant NSCLC by regulating the balance of angiogenic factors through HIF-1\u03b1\/VEGF","volume":"486","author":"Song","year":"2024","journal-title":"Toxicol. Appl pharm."},{"key":"10.1016\/j.micpath.2025.107409_bib13","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.fitote.2014.11.019","article-title":"A review of biotransformation and pharmacology of ginsenoside compound K","volume":"100","author":"Yang","year":"2015","journal-title":"Fitoterapia"},{"issue":"7","key":"10.1016\/j.micpath.2025.107409_bib14","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3390\/biom10071028","article-title":"Ginsenoside compound K: insights into recent studies on pharmacokinetics and health-promoting activities","volume":"10","author":"Sharma","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.micpath.2025.107409_bib15","article-title":"Biotransformation, pharmacokinetics, and pharmacological activities of ginsenoside rd against multiple diseases","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.micpath.2025.107409_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.952332","article-title":"Pharmacological effects of natural medicine ginsenosides against Alzheimer's disease","volume":"13","author":"Shi","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.micpath.2025.107409_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.arr.2018.04.004","article-title":"Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease","volume":"45","author":"Sun","year":"2018","journal-title":"Ageing. Res. Rev."},{"issue":"4","key":"10.1016\/j.micpath.2025.107409_bib18","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.3233\/JPD-212707","article-title":"Parkinson's disease and the gut: symptoms, nutrition, and microbiota","volume":"11","author":"Yemula","year":"2021","journal-title":"J. Parkinson. Dis."},{"issue":"6","key":"10.1016\/j.micpath.2025.107409_bib19","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.3390\/ijms19061689","article-title":"Microbiome-gut-brain Axis and toll-like receptors in Parkinson's disease","volume":"19","author":"Caputi","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.micpath.2025.107409_bib20","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s40168-021-01107-9","article-title":"Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis","volume":"9","author":"Zhao","year":"2021","journal-title":"Microbiome"},{"issue":"1","key":"10.1016\/j.micpath.2025.107409_bib21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/cns.13990","article-title":"Gut bacterial profiles in Parkinson's disease: a systematic review","volume":"29","author":"Li","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.micpath.2025.107409_bib22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbi.2018.02.005","article-title":"Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: gut microbiota, glial reaction and TLR4\/TNF-\u03b1 signaling pathway","volume":"70","author":"Sun","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.micpath.2025.107409_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.887407","article-title":"Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease","volume":"12","author":"Cui","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"4","key":"10.1016\/j.micpath.2025.107409_bib24","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1021\/acs.jafc.1c07711","article-title":"Lactobacillus plantarum DP189 reduces \u03b1-SYN aggravation in MPTP-induced Parkinson's disease mice via regulating oxidative damage, inflammation, and gut microbiota disorder","volume":"70","author":"Wang","year":"2022","journal-title":"J. Agric. Food Chem."},{"issue":"5","key":"10.1016\/j.micpath.2025.107409_bib25","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1007\/s11033-019-04988-0","article-title":"Ginsenoside compound K ameliorates Alzheimer's disease in HT22 cells by adjusting energy metabolism","volume":"46","author":"Chen","year":"2019","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.micpath.2025.107409_bib26","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s12031-018-1210-3","article-title":"Ginsenoside compound K regulates amyloid \u03b2 via the Nrf2\/Keap1 signaling pathway in mice with scopolamine hydrobromide-induced memory impairments","volume":"67","author":"Yang","year":"2019","journal-title":"J. Mol. Neurosci."},{"issue":"13","key":"10.1016\/j.micpath.2025.107409_bib27","doi-asserted-by":"crossref","first-page":"7183","DOI":"10.3390\/ijms25137183","article-title":"A comprehensive approach to Parkinson's disease: addressing its molecular, clinical, and therapeutic aspects","volume":"25","author":"Muleiro Alvarez","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2025.107409_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.655819","article-title":"Genetic imaging of neuroinflammation in Parkinson's disease: recent advancements","volume":"9","author":"Yao","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.micpath.2025.107409_bib29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/diseases11030089","article-title":"WNT-\u03b2 catenin signaling as a potential therapeutic target for neurodegenerative diseases: current status and future perspective","volume":"11","author":"Ramakrishna","year":"2023","journal-title":"Diseases"},{"key":"10.1016\/j.micpath.2025.107409_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchemneu.2016.11.009","article-title":"Mucuna pruriens reduces inducible nitric oxide synthase expression in Parkinsonian mice mode","volume":"80","author":"Yadav","year":"2017","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.micpath.2025.107409_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2020.101752","article-title":"Advancement in the modelling and therapeutics of Parkinson's disease","volume":"104","author":"Rai","year":"2020","journal-title":"J. Chem. Neuroanat."},{"issue":"1","key":"10.1016\/j.micpath.2025.107409_bib32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40035-023-00392-8","article-title":"Parkinson's disease and gut microbiota: from clinical to mechanistic and therapeutic studies","volume":"12","author":"Zhang","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.micpath.2025.107409_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102177","article-title":"Gut microbiome-mediated regulation of neuroinflammation","volume":"76","author":"Bostick","year":"2022","journal-title":"Curr. Opin. Immunol."},{"issue":"9996","key":"10.1016\/j.micpath.2025.107409_bib34","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2025.107409_bib35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fnagi.2020.00004","article-title":"Strategies for the treatment of Parkinson's disease: beyond dopamine","volume":"12","author":"Iarkov","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.micpath.2025.107409_bib36","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1007\/s11064-014-1443-7","article-title":"Withania somnifera alleviates parkinsonian phenotypes by inhibiting apoptotic pathways in dopaminergic neurons","volume":"39","author":"Prakash","year":"2014","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.micpath.2025.107409_bib37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jchemneu.2015.12.002","article-title":"Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model","volume":"71","author":"Rai","year":"2016","journal-title":"J. Chem. Neuroanat."},{"issue":"19","key":"10.1016\/j.micpath.2025.107409_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911054","article-title":"Striatal neurons partially expressing a dopaminergic phenotype: functional significance and regulation","volume":"23","author":"Troshev","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2025.107409_bib39","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3389\/fphar.2020.00356","article-title":"Modeling Parkinson's disease with the alpha-synuclein protein","volume":"11","author":"G\u00f3mez-Benito","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.micpath.2025.107409_bib40","first-page":"422","article-title":"MPTP-induced mouse model of Parkinson's disease: a promising direction for therapeutic strategies","volume":"21","author":"Mustapha","year":"2021","journal-title":"Bosnian J Basic Med."},{"key":"10.1016\/j.micpath.2025.107409_bib41","article-title":"New insights in animal models of neurotoxicity-induced neurodegeneration","volume":"17","author":"Sanfeliu","year":"2024","journal-title":"Front Neurosci-switz"},{"key":"10.1016\/j.micpath.2025.107409_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2024.116446","article-title":"CDK5-USP30 signaling pathway regulates MAVS-mediated inflammation via suppressing mitophagy in MPTP\/MPP+ PD model","volume":"279","author":"Ren","year":"2024","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"1","key":"10.1016\/j.micpath.2025.107409_bib43","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41540-020-00150-w","article-title":"ROS networks: designs, aging, Parkinson's disease and precision therapies","volume":"6","author":"N Kolodkin","year":"2020","journal-title":"NPJ. Syst. Biol. Appl."},{"key":"10.1016\/j.micpath.2025.107409_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.743754","article-title":"Parkinson's disease dementia: synergistic effects of alpha-synuclein, tau, beta-amyloid, and iron","volume":"13","author":"Han","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"7","key":"10.1016\/j.micpath.2025.107409_bib45","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3390\/antiox9070597","article-title":"The role of oxidative stress in Parkinson's disease","volume":"9","author":"Chang","year":"2020","journal-title":"Antioxidants-Basel"},{"key":"10.1016\/j.micpath.2025.107409_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112706","article-title":"Neuroprotective effects of Tongtian oral liquid, a Traditional Chinese Medicine in the Parkinson's disease-induced zebrafish model","volume":"148","author":"Dongjie","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.micpath.2025.107409_bib47","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12974-022-02496-w","article-title":"The role of Toll-like receptors and neuroinflammation in Parkinson's disease","volume":"19","author":"Heidari","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.micpath.2025.107409_bib48","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40035-021-00271-0","article-title":"TLR2 and TLR4 in Parkinson's disease pathogenesis: the environment takes a toll on the gut","volume":"10","author":"Gorecki","year":"2021","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.micpath.2025.107409_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101812","article-title":"Role of enteric glia and microbiota-gut-brain axis in Parkinson disease pathogenesis","volume":"84","author":"Claudino Dos Santos","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.micpath.2025.107409_bib50","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41531-023-00511-2","article-title":"Gastrointestinal disorders in Parkinson's disease and other Lewy body diseases","volume":"9","author":"Hirayama","year":"2023","journal-title":"NPJ. Parkinsons. Dis."},{"issue":"6","key":"10.1016\/j.micpath.2025.107409_bib51","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1039\/D3FO05169B","article-title":"Gastrodia elata polysaccharide alleviates Parkinson's disease via inhibiting apoptotic and inflammatory signaling pathways and modulating the gut microbiota","volume":"15","author":"Gan","year":"2024","journal-title":"Food Funct."},{"issue":"11","key":"10.1016\/j.micpath.2025.107409_bib52","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.micpath.2025.107409_bib53","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2174\/1381612822666151125000300","article-title":"Inflammatory process in alzheimer's and Parkinson's diseases: central role of cytokines","volume":"22","author":"Alam","year":"2016","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.micpath.2025.107409_bib54","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41583-018-0093-1","article-title":"Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases","volume":"20","author":"Yuan","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.micpath.2025.107409_bib55","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1134\/S0022093024040173","article-title":"Role of apoptosis-related proteins P53 and bcl-2 in the pathogenesis of nervous system diseases","volume":"60","author":"Bazhanova","year":"2024","journal-title":"J. Evol. Biochem. Physiol."},{"issue":"2","key":"10.1016\/j.micpath.2025.107409_bib56","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1021\/acschemneuro.8b00356","article-title":"Balancing apoptosis and autophagy for Parkinson's disease therapy: targeting BCL-2","volume":"10","author":"Liu","year":"2019","journal-title":"CS Chem. Neurosci."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025001342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025001342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T03:16:48Z","timestamp":1741922208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401025001342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":56,"alternative-id":["S0882401025001342"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107409","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effect of ginsenoside CK against MPTP-induced Parkinson\u2019 s disease mouse model by suppressing oxidative stress and inflammation, and modulating the gut microbiota","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107409"}}